JM
John McNeil
Investor·Norwest
John McNeil is a Norwest investor focused on venture opportunities in healthcare, including digital health, healthcare IT, technology-enabled healthcare services, medical devices, diagnostics, and biopharma. Before joining Norwest, he spent three years at ClearView Healthcare Partners advising life sciences clients on R&D and commercial strategy and conducting due diligence on potential M&A targets. His Norwest active companies include Engrail Therapeutics, Ouro Medicines, and Zenas BioPharma.
See the rest of John McNeil's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.